Skip to main content
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc. — Investor Relations & Filings

Ticker · OVID ISIN · US6904691010 LEI · 549300H36NUI4L6U8F17 US Manufacturing
Filings indexed 497 across all filing types
Latest filing 2025-06-25 Regulatory Filings
Country US United States of America
Listing US OVID

About Ovid Therapeutics Inc.

https://ovidrx.com/

Ovid Therapeutics Inc. is a biopharmaceutical company that develops targeted small molecule therapies for neurological conditions. The company's primary focus is on conquering epilepsies and other brain disorders by creating treatments that aim to reduce seizures and offer improved safety and tolerability. Ovid's scientific approach involves pioneering compounds with unique or potentially best-in-class mechanisms of action to address significant unmet medical needs. The company's mission is to develop medicines that improve the lives of patients and families affected by these conditions.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The content describes an amendment to a patent license agreement and related financial terms, which is a specific event disclosure. It is not a full financial report like an Annual Report (10-K) or Quarterly Report (10-Q), nor is it a transcript, proxy, or other specialized filing. The document length is under 5,000 characters and it includes detailed event information rather than just announcing a report publication. Therefore, the filing type corresponds to a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories but are regulatory announcements.
2025-06-25 English
Director's Dealing 2025
Director's Dealing
2025-06-18 English
Director's Dealing 2025
Director's Dealing
2025-06-18 English
Director's Dealing 2025
Director's Dealing
2025-06-18 English
Director's Dealing 2025
Director's Dealing
2025-06-18 English
ARS
Annual Report
2025-05-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.